Attached files
file | filename |
---|---|
10-Q - Benda Pharmaceutical, Inc. | v203300_10q.htm |
EX-31.1 - Benda Pharmaceutical, Inc. | v203300_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
OF
CHIEF
EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350
In
connection with this Quarterly Report of Benda Pharmaceutical,
Inc. (the “Company”) on Form 10-Q for the period
ending September 30, 2010, as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Yiqing Wan, Chief Executive
Officer and Chief Financial Officer of the Company, certifies to the best of his
knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of
the Sarbanes-Oxley Act of 2002, that:
1.
|
Such
Quarterly Report on Form 10-Q for the period ending September
30, 2010, fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in such Quarter Report on Form 10-Q for
the period ending September 30, 2010, fairly presents, in all
material respects, the financial condition and results of operations of
Benda Pharmaceutical Inc.;
|
Date: 11/22/10 | ||||
/s/
Yiqing Wan
|
|
|||
Chief
Executive Officer
|
|
|||
Chief
Financial Officer
|
|